🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Rite Aid Confirms It Rejected Spear Point's Acquisition Offer

Published 04/21/2022, 04:39 AM
Updated 04/21/2022, 09:11 AM
© Reuters.  Rite Aid (RAD) Confirms It Rejected Spear Point's Acquisition Offer
US90274J5618=UBSS
-

Rite Aid Corp (NYSE:RAD) said today that it rejected an offer from Spear Point Capital Management to acquire all of its shares.

Spear Point made an offer to acquire all of the outstanding shares.

“The Company and its Board of Directors reviewed the proposal with the assistance of its financial and legal advisors, and the Board concluded that the proposal was not credible and did not warrant further exploration,” Rite Aid said in a statement.

The pharmacy chain said that the “Spear Point proposal provided no evidence of financing, required multiple months of exclusivity and then called for Rite Aid to spend months soliciting competing offers.”

Additionally, Spear Capital “has no track record of acquiring public companies the size and complexity of Rite Aid.”

On Wednesday, the New York Post reported that an unnamed private equity firm made an offer of $815 million for RAD. As a result, Spear Point is now considering launching a hostile tender offer directly to shareholders.

Rite Aid had a market capitalization of $392.7 million based on Wednesday's closing price.

Rite Aid stock price is down 2.5% in pre-open Thursday.

By Senad Karaahmetovic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.